Connect with us

Hi, what are you looking for?

Jewish Business News


Charles Bronfman Celebrates McGill’s Institute For the Study of Canada


Charles Bronfman wrote a piece for the Montreal Gazette to commemorate the 20th anniversary of the McGill Institute for the Study of Canada (Or MISC). Bronfman went on to praise Canada’s diversity, enduring government system and unique culture. “We are a haven of civility–yes, of peace, order and good government in a tumultuous world.”

“It is a tribute to Canadians past and present that the problems we face are those of a democratic and prosperous society … It is important we continually challenge ourselves to do better.”

“We need access to knowledge and information with which to test our beliefs and assumptions about our past, present and future. That is why the McGill Institute for the Study of Canada was created 20 years ago, and why I believe its mission remains as critical as ever. Its mandate includes teaching, research, and, closest to my heart, public education.”

“Like any proud parent, it gives me great joy to see all MISC has accomplished. It continues to challenge stereotypes of Canada as a polite, boring country (anyone who ever thinks that has never entered a sports bar during hockey playoffs or tuned into a Question Period.) MISC continues to create and shape the policy of our country. It continues to mine our rich history, to examine our ever-evolving present, and to keep an eye on the future, so full of possibility.”

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...


The contract signed between the Israeli government and Pfizer shows clearly and unequivocally that this is a clinical study on humans - The agreement...


Now Platika joins and elite club of $10 billion plus Israeli firms.